Nab-Paclitaxel and Carboplatin (Nab-PC) Regimen for Advanced Non-Small-Cell Lung Cancer

Mancheril, Benjamin; Waddell, J. Aubrey; Solimando, Dominic A.

doi:10.1310/hpj4909-804

Search citation statements

Order By: Relevance

Paper Sections

Select...

Discussion1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Therefore, novel treatment is needed to improve the outcomes of AWT. Currently, nab-paclitaxel plus carboplatin (Nab-PC) has been extensively studied in advanced non-small-cell lung cancer [ 16 , 17 ], breast cancer [ 18–20 ], esophageal cancer [ 21 ] and ovarian cancer [ 22 ]. A number of clinical studies showed that nab-paclitaxel and carboplatin have good effectiveness and safety.…”

Section: Discussionmentioning

confidence: 99%

Metastatic adult Wilms' tumor managed by chemotherapy, immunotherapy and target therapy: a case report

Zhao,

Xiong,

Song

2024

Future Science OA

View full text Add to dashboard Cite

Wilms' tumor is a rare type of tumor in adult. Herein, we reported a case of 37-year-old female with adult Wilms' tumor (AWT) admitted in our institution. After a multidisciplinary team discussion, she underwent receiving immunotherapy plus chemotherapy and VEGF-targeted therapy. The tumor got smaller obviously after eight cycles of treatment. Our present case suggested that immunotherapy and anti-angiogenesis combined with chemotherapy is promising new approach for treating AWT. Moreover, we review the literatures reporting AWT with the purpose to improve the understanding of AWT treatment.

show abstract